SEC Comment Letter for Hemp Technology, Inc. (CIK 0001797956) — Jun 16, 2021
Hemp Technology, Inc. (CIK 0001797956)
Date: June 16, 2021 · CIK: 0001797956 · Accession: 0000000000-21-007432
AI Filing Summary & Sentiment
File numbers found in text: 024-11548
Letter
United States securities and exchange commission logo June 16, 2021 Michael Shenher Chief Executive Officer RCMW Group, Inc. 2232 Dell Range Blvd., Ste 245 Cheyenne, WY 82009 Re:RCMW Group, Inc. Offering Statement on Form 1-A Filed June 11, 2021 File No. 024-11548 Dear Mr. Shenher: This is to advise you that we do not intend to review your offering statement. We will consider qualifying your offering statement at your request. If a participant in your offering is required to clear its compensation arrangements with FINRA, please have FINRA advise us that it has no objections to the compensation arrangements prior to qualification. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. We also remind you that, following qualification of your Form 1-A, Rule 257 of Regulation A requires you to file periodic and current reports, including a Form 1-K which will be due within 120 calendar days after the end of the fiscal year covered by the report. Please contact Irene Paik at 202-551-6553 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: TJ Jesky
Show Raw Text
United States securities and exchange commission logo
June 16, 2021
Michael Shenher
Chief Executive Officer
RCMW Group, Inc.
2232 Dell Range Blvd., Ste 245
Cheyenne, WY 82009
Re:RCMW Group, Inc.
Offering Statement on Form 1-A
Filed June 11, 2021
File No. 024-11548
Dear Mr. Shenher:
This is to advise you that we do not intend to review your offering statement.
We will consider qualifying your offering statement at your request. If a participant in
your offering is required to clear its compensation arrangements with FINRA, please have
FINRA advise us that it has no objections to the compensation arrangements prior to
qualification.
We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff. We also remind you that, following qualification of your Form 1-A, Rule 257
of Regulation A requires you to file periodic and current reports, including a Form 1-K which
will be due within 120 calendar days after the end of the fiscal year covered by the report.
Please contact Irene Paik at 202-551-6553 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: TJ Jesky